[{"AccountsPayableTradeCurrent_0_Q3_USD":7222000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.01,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":465000.0,"PaymentsForRepurchaseOfCommonStock_3_Q3_USD":230000.0,"OtherOperatingIncomeExpenseNet_3_Q3_USD":-7873000.0,"OtherOperatingIncomeExpenseNet_1_Q3_USD":-3719000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":3138000.0,"OtherLiabilitiesCurrent_0_Q3_USD":5043000.0,"OtherComprehensiveIncomeLossNetOfTax_3_Q3_USD":7890000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q3_USD":3657000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_3_Q3_USD":7890000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q3_USD":3657000.0,"PreferredStockSharesAuthorized_0_Q3_shares":50000000.0,"OtherAssetsNoncurrent_0_Q3_USD":6516000.0,"OperatingIncomeLoss_1_Q3_USD":-39181000.0,"OperatingExpenses_3_Q3_USD":119618000.0,"OperatingExpenses_1_Q3_USD":42414000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_3_Q3_USD":-23068000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_1_Q3_USD":57086000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_3_Q3_USD":-23068000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q3_USD":57086000.0,"NetIncomeLoss_3_Q3_USD":-23068000.0,"NetIncomeLoss_1_Q3_USD":57086000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-93668000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":102922000.0,"OperatingIncomeLoss_3_Q3_USD":-111991000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":2389000.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"PreferredStockValue_0_Q3_USD":null,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":19197536.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":19651243.0,"TreasuryStockValue_0_Q3_USD":230000.0,"TreasuryStockCommonShares_0_Q3_shares":7760.0,"StockRepurchasedAndRetiredDuringPeriodValue_1_Q3_USD":230000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q3_USD":6706000.0,"StockIssuedDuringPeriodValueNewIssues_19_Q3_USD":356900000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q3_USD":241000.0,"StockholdersEquity_0_Q3_USD":181716000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3_Q3_USD":34.82,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_Q3_shares":824450.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"ShareBasedCompensation_3_Q3_USD":13272000.0,"SellingGeneralAndAdministrativeExpense_1_Q3_USD":17612000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":8058000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":3664000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-289888000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":61920000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":21083000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":775000.0,"ProfitLoss_3_Q3_USD":-23068000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_3_Q3_USD":2378000.0,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":241000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":7779000.0,"SellingGeneralAndAdministrativeExpense_3_Q3_USD":49825000.0,"LongTermNotesPayable_0_Q3_USD":9929000.0,"LiabilitiesCurrent_0_Q3_USD":33149000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":296445000.0,"DepreciationDepletionAndAmortization_3_Q3_USD":167000.0,"CostOfRevenue_3_Q3_USD":431000.0,"CostOfRevenue_1_Q3_USD":431000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-15178000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":60743000.0,"CommonStockValue_0_Q3_USD":193000.0,"CommonStockSharesOutstanding_0_Q3_shares":19275509.0,"CommonStockSharesIssued_0_Q3_shares":19283269.0,"CommonStockSharesAuthorized_0_Q3_shares":60000000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.01,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":11340000.0,"EarningsPerShareBasic_1_Q3_USD":2.96,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":262612000.0,"AssetsCurrent_0_Q3_USD":271894000.0,"Assets_0_Q3_USD":296445000.0,"AmortizationOfFinancingCostsAndDiscounts_3_Q3_USD":308000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q3_USD":0.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":13272000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":6706000.0,"AdditionalPaidInCapital_0_Q3_USD":472363000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":-722000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":20884000.0,"AccretionExpense_3_Q3_USD":9428000.0,"AccountsReceivableNetCurrent_0_Q3_USD":1307000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":262612000.0,"EarningsPerShareBasic_3_Q3_USD":-1.2,"EarningsPerShareDiluted_1_Q3_USD":2.9,"EarningsPerShareDiluted_3_Q3_USD":-1.2,"Liabilities_0_Q3_USD":114729000.0,"InventoryWriteDown_3_Q3_USD":0.0,"InventoryWriteDown_1_Q3_USD":0.0,"InventoryNet_0_Q3_USD":196000.0,"InventoryFinishedGoodsNetOfReserves_0_Q3_USD":196000.0,"InterestIncomeExpenseNonoperatingNet_3_Q3_USD":-10675000.0,"InterestIncomeExpenseNonoperatingNet_1_Q3_USD":-3331000.0,"IncreaseDecreaseInPrepaidExpense_3_Q3_USD":-2765000.0,"IncreaseDecreaseInOtherOperatingLiabilities_3_Q3_USD":-3810000.0,"IncreaseDecreaseInOtherNoncurrentAssets_3_Q3_USD":-293000.0,"IncreaseDecreaseInInventories_3_Q3_USD":196000.0,"IncreaseDecreaseInAccruedLiabilities_3_Q3_USD":2068000.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":1307000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":2023000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":3789000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":3789000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":-19279000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":60875000.0,"GrossProfit_3_Q3_USD":7627000.0,"GrossProfit_1_Q3_USD":3233000.0,"Goodwill_0_Q3_USD":17260000.0,"GainLossOnDispositionOfIntangibleAssets_3_Q3_USD":103387000.0,"GainLossOnDispositionOfIntangibleAssets_1_Q3_USD":103387000.0,"ForeignCurrencyTransactionGainLossBeforeTax_3_Q3_USD":-7776000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_Q3_USD":-303000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":19258905.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":19197536.0,"Ticker":"ALBO","CIK":"1322505","name":"ALBIREO PHARMA, INC.","OfficialName":"Albireo Pharma Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"688702712.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211104"}]